Our latest article from the Nanomedicine group has been published in Biomaterials Advances!
Five research groups joined forces to develop a novel hybrid drug delivery system for nucleic acid therapeutics. By combining genipin-spermine-glycine nanoparticles with biomimetic erythrocyte membrane vesicles, we achieved an efficient and biocompatible carrier for siRNA delivery. Our system demonstrated:
•Excellent siRNA binding and protection against degradation
•Enhanced cellular uptake and gene silencing efficiency in vitro
•Minimal cytotoxicity and improved storage stability
Read the full paper here: https://doi.org/10.1016/j.bioadv.2025.214537
#DrugDelivery #Nanomedicine #GeneTherapy #siRNA #Collaboration #ScientificResearch
